troglitazone has been researched along with adenosine diphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishizawa, M; Ishizuka, T; Itaya, S; Kajita, K; Kanoh, Y; Kimura, M; Miura, A; Muto, N; Wada, H; Yasuda, K | 1 |
Farmer, SR; Kelly, M; LeBrasseur, NK; Ruderman, NB; Saha, AK; Tomas, E; Tsao, TS | 1 |
2 other study(ies) available for troglitazone and adenosine diphosphate
Article | Year |
---|---|
Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
Topics: Adenosine Diphosphate; Blood Platelets; Blood Proteins; Chromans; Collagen; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Hypoglycemic Agents; In Vitro Techniques; Isoenzymes; Kinetics; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Phosphorylation; Pioglitazone; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Thiazoles; Thiazolidinediones; Thrombin; Troglitazone; Vitamin E | 1998 |
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues.
Topics: Acetyl-CoA Carboxylase; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Chromans; Enzyme Activation; Fatty Acids; Glucose; Hypoglycemic Agents; In Vitro Techniques; Male; Mice; Multienzyme Complexes; Muscle, Skeletal; Oxidation-Reduction; PPAR gamma; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Swiss 3T3 Cells; Thiazolidinediones; Troglitazone | 2006 |